Hassan Solhi

Hassan Solhi

Auto-generated profile, based on publicly available information

Hassan Solhi

Clinical Toxicologist & Professor, Department of Forensic Medicine, School of Medicine, Arak University of Medical Sciences, Arak, Iran

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2005 in Environmental Toxicology and Pharmacology
Verified
Journal Article
Closed access
ARAkram Ranjbar
Akram Ranjbar
HSHasan Solhi
Hasan Solhi
FJFarideh Jalali-Mashayekhi
Farideh Jalali-Mashayekhi
ASAlireza Susanabdi
Alireza Susanabdi
ARAli Rezaie
Ali Rezaie
MAMohammad Abdollahi
Mohammad Abdollahi

1 January 2014
Verified
Journal Article
Closed access
HSHassan Solhi
Hassan Solhi
RGRamin Ghahremani
Ramin Ghahremani
AKAmir Mohammad Kazemifar
Amir Mohammad Kazemifar
ZYZahra Hoseini Yazdi
Zahra Hoseini Yazdi

1 June 2013 in Immunology Letters
Verified
Journal Article
Closed access
AGAli Ghazavi
Ali Ghazavi
GMGhasem Mosayebi
Ghasem Mosayebi
HSHassan Solhi
Hassan Solhi
MRMohammad Rafiei
Mohammad Rafiei
SMSeyed Mohammad Moazzeni
Seyed Mohammad Moazzeni

20 May 2014 in Drug Metabolism Letters
Verified
Journal Article
Closed access
HSHassan Solhi
Hassan Solhi
AMAliakbar Malekirad
Aliakbar Malekirad
AKAmir Kazemifar
Amir Kazemifar
FSFarzaneh Sharifi
Farzaneh Sharifi
Background and Aims: Methamphetamine abuse results in numerous adverse health effects. Formation of free radicals may be a contributing factor. Methamphetamine has produced free radicals in animal studies. Present study was conducted to evaluate status of oxidative stress and lipid peroxidation among chronic methamphetamine users. Methods: Ninety six individuals were selected randomly from methamphetamine abusers who had referred to rehabilitation and treatment center for drug abuse and their closed relatives, after providing informed consent. Blood samples were taken from each of the studied individuals. Ferric reducing ability of plasma (FRAP) assay and serum level of MDA (malondialdehyde) were used to assess the total anti-oxidant power and status of lipid peroxidation of the body, respectively. The results were analyzed by SPSS software version 16.0. Differences among groups were determined by T-test. Findings: Total anti-oxidant powers of plasma were 0.31±0.04 micromoles/liter and 0.46±0.05 micromoles/liter in methamphetamine abusers and control groups respectively. The difference was statistically significant (p-value=0.04). Levels of MDA were 4.38±5.05 micromoles/liter and 1.72±2.04 micromoles/liter in methamphetamine abusers and control group. The difference was statistically significant (p-value=0.01). Conclusion: results of present study suggest that prolonged use of methamphetamine exerts oxidative stress on the body and enhances lipid peroxidation. The event may contribute to emergence of adverse effects of acute and prolonged use of methamphetamine; such as loss of attention, psychomotor dysfunction, and cognitive deficits. It is recommended that antioxidants were included in drug regimens prescribed for methamphetamine abusers who referred to physicians to seek medical care for any reason.

1 May 2013 in Journal of Addiction Medicine
Verified
Journal Article
Closed access
AGAli Ghazavi
Ali Ghazavi
HSHassan Solhi
Hassan Solhi
SMSeyed Mohammad Moazzeni
Seyed Mohammad Moazzeni
MRMohammad Rafiei
Mohammad Rafiei
GMGhasem Mosayebi
Ghasem Mosayebi
Objectives: There are few studies with conflicting results on the effects of in vivo administration of opioids on immune function. The aim of this study was to evaluate the serum levels of interferon (IFN)-γ, interleukin (IL)-4, IL-10, IL-17, and hs-C-reactive protein (hs-CRP) in opium smokers. Methods: The study was conducted between 44 male opium addicts and 44 controls aged 20 to 40 years. The control group was healthy individuals with no lifetime history of substance abuse. All the opium abusers were selected from those who had a history of use of opium, as a regular habit, at least for 1 year, with a daily opium dosage of not less than 2 g. Addicts known to abuse alcohol or other drugs were excluded. Serum samples were collected from all participants and tested for the cytokine and hs-CRP levels by ELISA (enzyme-linked immunosorbent assay) method. Statistical analysis was performed using the Student t test. Results: The mean serum levels of IFN-γ, IL-10, and IL-17 in the opium addicts were significantly higher than those observed in the control group. The mean concentration of serum IL-4 in opium addicts did not differ from that in the control group. Systemic IL-10 levels correlated positively and significantly with CRP in opium addicts. Conclusions: Long-term, daily use of opium is associated with higher Th1 (IFN-γ), Tr1 (IL-10), and Th17 (IL-17) cytokines concentration in serum. Interferon-γ and IL-17 are involved in inducing and mediating proinflammatory responses. Our data suggest that an immunoregulatory response is occurring with the upregulation of IL-10.

1 October 2012 in The Journal of Emergency Medicine
Verified
Journal Article
Closed access
HSHassan Solhi
Hassan Solhi
SPShirin Pazoki
Shirin Pazoki
OMOmid Mehrpour
Omid Mehrpour
SASam Alfred
Sam Alfred